Literature DB >> 6319766

Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12-o-tetradecanoylphorbol-13-acetate and sodium butyrate.

T Ooka, M De Turenne, G De The, J Daillie.   

Abstract

An Epstein-Barr virus (EBV)-specific DNase was induced in EBV nonproducer Raji cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and sodium butyrate. The increase in EBV DNase activity was related to the appearance of early antigen-positive cells. The enzyme had a sedimentation coefficient of 4S and was resistant to 300 mM KCl, and its induction did not depend on viral DNA synthesis. The EBV-specific DNase activity was specifically inhibited by sera from patients who had nasopharyngeal carcinoma with high early antigen activities but not by sera from normal, healthy individuals. There was a correlation between the degree of anti-EBV DNase activity and the titers of early antigen antibody.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319766      PMCID: PMC255511     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  The deoxyribonuclease induced after infection of KB cells by herpes simplex virus type 1 or type 2. I. Purification and characterization of the enzyme.

Authors:  P J Hoffmann; Y C Cheng
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

2.  Characterization of an Epstein-Barr virus-induced DNA polymerase.

Authors:  T Ooka; G Lenoir; J Daillie
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Characterization of herpes simplex virus-induced deoxyribonucleic acid polymerase.

Authors:  A Weissbach; S C Hong; J Aucker; R Muller
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.

Authors:  A T Jamieson; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  An endonuclease isolated from Epstein-Barr virus-producing human lymphoblastoid cells.

Authors:  W Clough
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Studies on the activity of DNase associated with the replication of the Epstein-Barr virus.

Authors:  Y C Cheng; J Y Chen; P J Hoffmann; R Glaser
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

8.  Effects of arabinofuranosylthymine on Epstein-Barr virus replication.

Authors:  T Ooka; A Calender
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

9.  Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity.

Authors:  T Ooka; A Calender; M de Turenne; J Daillie
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

10.  Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.

Authors:  Y C Cheng; J Y Chen; R Glaser; W Henle
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  10 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria.

Authors:  S Asai; Y Nakamura; M Yamamura; H Ikezawa; I Namikawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Identification of an Epstein-Barr virus-specific desoxyribonuclease gene using complementary DNA.

Authors:  C X Zhang; G Decaussin; M de Turenne Tessier; J Daillie; T Ooka
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

4.  Characterization of an Epstein-Barr virus-induced thymidine kinase.

Authors:  M de Turenne-Tessier; T Ooka; G de The; J Daillie
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Specific immune serum to the Epstein-Barr virus DNA polymerase.

Authors:  R G Petit; K Leung; J E Shaw
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.

Authors:  T Ooka; G M Lenoir; G Decaussin; G W Bornkamm; J Daillie
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

7.  Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli.

Authors:  M C Stolzenberg; T Ooka
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

Authors:  G Decaussin; V Leclerc; T Ooka
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Branched structures in the intracellular DNA of herpes simplex virus type 1.

Authors:  A Severini; D G Scraba; D L Tyrrell
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

10.  A transforming function of the BARF1 gene encoded by Epstein-Barr virus.

Authors:  M X Wei; T Ooka
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.